Enzo Biochem, Inc. (EZB.F)
- Previous Close
1.0100 - Open
1.0000 - Bid 1.0000 x 120000
- Ask 1.0400 x 120000
- Day's Range
1.0000 - 1.0000 - 52 Week Range
1.0000 - 2.4000 - Volume
2,430 - Avg. Volume
67 - Market Cap (intraday)
51.892M - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4400 - Earnings Date Jun 12, 2024 - Jun 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.
www.enzo.comRecent News: EZB.F
Performance Overview: EZB.F
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EZB.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EZB.F
Valuation Measures
Market Cap
52.41M
Enterprise Value
2.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.64
Price/Book (mrq)
0.78
Enterprise Value/Revenue
0.08
Enterprise Value/EBITDA
-0.16
Financial Highlights
Profitability and Income Statement
Profit Margin
99.28%
Return on Assets (ttm)
-16.53%
Return on Equity (ttm)
-45.01%
Revenue (ttm)
32.8M
Net Income Avi to Common (ttm)
-23.32M
Diluted EPS (ttm)
-0.4400
Balance Sheet and Cash Flow
Total Cash (mrq)
60.24M
Total Debt/Equity (mrq)
10.15%
Levered Free Cash Flow (ttm)
-4.44M
Company Insights: EZB.F
EZB.F does not have Company Insights